REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Spell Organics Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Spell Organics Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Spell Organics Limited manufactures SOL Sorbitan monostearate (SMS), also known as SPAN 60, using raw materials. They supply property enhancers to bakeries, breweries, and confectioneries.

Legal Address
16/2-B, Ansari Road Daryaganj
Central Delhi; Delhi; Postal Code: 110002

Contact Details: Purchase the Spell Organics Limited report to view the information.

Website: http://www.spellorganics.com

Basic Information
Total Employees:
Purchase the Spell Organics Limited report to view the information.
Outstanding Shares:
Purchase the Spell Organics Limited report to view the information.
Registered Capital:
Purchase the Spell Organics Limited report to view the information.
Incorporation Date:
June 07, 1988
Key Executives
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Professional Director
Ownership Details
Purchase this report to view the information.
19.04%
Purchase this report to view the information.
0.02%
Purchase this report to view the information.
0.02%
Company Performance
Financial values in the chart are available after Spell Organics Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
28.64%▲
Total operating revenue
28.48%▲
Operating profit (EBIT)
54.65%▲
EBITDA
38.43%▲
Net Profit (Loss) for the Period
40.17%▲
Total assets
9.26%▲
Total equity
-0.36%▼
Operating Profit Margin (ROS)
0.2%▲
Net Profit Margin
0.06%▲
Return on Equity (ROE)
3.05%▲
Debt to Equity Ratio
87.98%▲
Quick Ratio
0.28%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo